Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector.
Jiayu A TaiTomoyuki NishikawaHiroki HayashiYu-Diao KuanKunihiko YamashitaHironori NakagamiPublished in: Vaccines (2024)
mRNA vaccines were successfully developed and approved for emergency use to fight coronavirus disease 2019. However, the effect of DNA vaccines against SARS-CoV-2 is considerably lower than that of mRNA vaccines. A pyro-drive jet injector (PJI) efficiently delivers plasmid DNA intradermally into animal models. Here, we compared the immunogenic potential of DNA and mRNA vaccines in mice using the same platform. PJI was used to deliver naked mRNA and pDNA and their efficacy in inducing antigen expression and immune responses was assessed. Our results showed that PJI efficiently delivered mRNA into the skin, and a smaller effective dose than that of pDNA injection was required to achieve similar levels of antigen expression. The PJI-delivered CpG-free pDNA vaccine efficiently induced antigen-specific antibody production and a cell-mediated IFN-γ response compared to the mRNA vaccine, as well as the upregulation of inflammatory cytokines (IL-6, IFN-γ, and IL-1β) in the skin and lymph nodes. However, the intradermal mRNA vaccine was significantly less immunogenic than the standard intramuscular mRNA-lipid nanoparticle vaccine, despite equivalent mRNA dosages. Improvements in lipid nanoparticle and mRNA technology have revolutionized mRNA vaccines, and DNA vaccines can be similarly modified for higher clinical efficacy.
Keyphrases
- binding protein
- immune response
- nucleic acid
- sars cov
- coronavirus disease
- lymph node
- poor prognosis
- healthcare
- circulating tumor
- emergency department
- public health
- single molecule
- cell free
- escherichia coli
- type diabetes
- stem cells
- dendritic cells
- early stage
- crispr cas
- high frequency
- single cell
- skeletal muscle
- toll like receptor
- climate change
- rectal cancer
- long non coding rna
- mesenchymal stem cells
- respiratory syndrome coronavirus
- insulin resistance
- inflammatory response
- neoadjuvant chemotherapy
- drug induced
- locally advanced